These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10852059)

  • 21. In Vitro Fermentation of caprine milk oligosaccharides by bifidobacteria isolated from breast-fed infants.
    Thum C; Roy NC; McNabb WC; Otter DE; Cookson AL
    Gut Microbes; 2015; 6(6):352-63. PubMed ID: 26587678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria.
    Bordoni A; Amaretti A; Leonardi A; Boschetti E; Danesi F; Matteuzzi D; Roncaglia L; Raimondi S; Rossi M
    Appl Microbiol Biotechnol; 2013 Sep; 97(18):8273-81. PubMed ID: 23872958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum.
    Gotoh A; Katoh T; Sakanaka M; Ling Y; Yamada C; Asakuma S; Urashima T; Tomabechi Y; Katayama-Ikegami A; Kurihara S; Yamamoto K; Harata G; He F; Hirose J; Kitaoka M; Okuda S; Katayama T
    Sci Rep; 2018 Sep; 8(1):13958. PubMed ID: 30228375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonistic activities of some Bifidobacterium sp. strains isolated from resident infant gastrointestinal microbiota on Gram-negative enteric pathogens.
    Delcaru C; Alexandru I; Podgoreanu P; Cristea VC; Bleotu C; Chifiriuc MC; Bezirtzoglou E; Lazar V
    Anaerobe; 2016 Jun; 39():39-44. PubMed ID: 26921694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
    Matsumoto T; Ishikawa H; Tateda K; Yaeshima T; Ishibashi N; Yamaguchi K
    J Appl Microbiol; 2008 Mar; 104(3):672-80. PubMed ID: 17927741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid identification of human intestinal bifidobacteria by 16S rRNA-targeted species- and group-specific primers.
    Matsuki T; Watanabe K; Tanaka R; Oyaizu H
    FEMS Microbiol Lett; 1998 Oct; 167(2):113-21. PubMed ID: 9809413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation of food-derived opioid peptides by bifidobacteria.
    Sakurai T; Yamada A; Hashikura N; Odamaki T; Xiao JZ
    Benef Microbes; 2018 Jun; 9(4):675-682. PubMed ID: 29633643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A molecular-and-genetic analysis of species and strain diversity of bifidobacteria in early childhood].
    Shkoporov AN; Kafarskaia LI; Afanas'ev SS; Smeianov VV; Kirillov MIu; Postnikova EA; Maksimov FE; Khokhlova EV; Efimov BA
    Vestn Ross Akad Med Nauk; 2006; (1):45-50. PubMed ID: 16496956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of tuf gene-based primers for the PCR detection of probiotic Bifidobacterium species and enumeration of bifidobacteria in fermented milk by cultural and quantitative real-time PCR methods.
    Sheu SJ; Hwang WZ; Chiang YC; Lin WH; Chen HC; Tsen HY
    J Food Sci; 2010 Oct; 75(8):M521-7. PubMed ID: 21535508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementary Mechanisms for Degradation of Inulin-Type Fructans and Arabinoxylan Oligosaccharides among Bifidobacterial Strains Suggest Bacterial Cooperation.
    Rivière A; Selak M; Geirnaert A; Van den Abbeele P; De Vuyst L
    Appl Environ Microbiol; 2018 May; 84(9):. PubMed ID: 29500265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of bifidobacteria to lysozyme as a possible selection criterion for probiotic bifidobacterial strains.
    Rada V; Splichal I; Rockova S; Grmanova M; Vlkova E
    Biotechnol Lett; 2010 Mar; 32(3):451-5. PubMed ID: 19943182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bifidobacterium bifidum ATCC 15696 and Bifidobacterium breve 24b Metabolic Interaction Based on 2'-
    Centanni M; Ferguson SA; Sims IM; Biswas A; Tannock GW
    Appl Environ Microbiol; 2019 Apr; 85(7):. PubMed ID: 30683741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissimilarity in the occurrence of Bifidobacteriaceae in vaginal and perianal microbiota in women with bacterial vaginosis.
    Swidsinski A; Dörffel Y; Loening-Baucke V; Mendling W; Schilling J; Patterson JL; Verstraelen H
    Anaerobe; 2010 Oct; 16(5):478-82. PubMed ID: 20620215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Species characteristic and factors of persistence of gut bifidoflora during healthy state and dysbiosis].
    Ivanova EV; Perunova NB; Valyshev AV; Valysheva IV; Bukharin OV
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):89-93. PubMed ID: 19462518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mupirocin-mucin agar for selective enumeration of Bifidobacterium bifidum.
    Pechar R; Rada V; Parafati L; Musilova S; Bunesova V; Vlkova E; Killer J; Mrazek J; Kmet V; Svejstil R
    Int J Food Microbiol; 2014 Nov; 191():32-5. PubMed ID: 25217723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antimicrobial action of low-molar-mass chitosan, chitosan derivatives and chitooligosaccharides on bifidobacteria.
    Simůnek J; Koppová I; Filip L; Tishchenko G; Bełzecki G
    Folia Microbiol (Praha); 2010 Jul; 55(4):379-82. PubMed ID: 20680576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New genetic environments of the macrolide-lincosamide-streptogramin resistance determinant erm(X) and their influence on potential horizontal transferability in bifidobacteria.
    Wang N; Hang X; Zhang M; Peng X; Yang H
    Int J Antimicrob Agents; 2017 Oct; 50(4):572-580. PubMed ID: 28666750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bifidobacterium Bacteremia: Clinical Characteristics and a Genomic Approach To Assess Pathogenicity.
    Esaiassen E; Hjerde E; Cavanagh JP; Simonsen GS; Klingenberg C;
    J Clin Microbiol; 2017 Jul; 55(7):2234-2248. PubMed ID: 28490487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditions affecting cell surface properties of human intestinal bifidobacteria.
    Canzi E; Guglielmetti S; Mora D; Tamagnini I; Parini C
    Antonie Van Leeuwenhoek; 2005; 88(3-4):207-19. PubMed ID: 16284927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products.
    Masco L; Van Hoorde K; De Brandt E; Swings J; Huys G
    J Antimicrob Chemother; 2006 Jul; 58(1):85-94. PubMed ID: 16698847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.